# BRIACELL THERAPEUTICS CORP: An Off-the-Shelf tumor cell vaccine with HLA-matching alleles for personalized treatment of advanced metastatic prostate cancer.

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | BRIACELL THERAPEUTICS CORP |
| Location | PHILADELPHIA, PA |
| Project | An Off-the-Shelf tumor cell vaccine with HLA-matching alleles for personalized treatment of advanced metastatic prostate cancer. |
| Project number | 5R44CA281555-03 |
| Mechanism | R44 |
| Institute | National Cancer Institute |
| Award | $947,870 |
| Awarded | 2026-09-09 |
| Project period | 2023-09-01 to 2027-07-31 |
| UEI | S4APLQN63FL6 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11398997). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.